KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
17.30
+1.07 (6.59%)
At close: Mar 9, 2026, 4:00 PM EDT
17.16
-0.14 (-0.81%)
After-hours: Mar 9, 2026, 6:35 PM EDT
KalVista Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Revenue | 1.43 | - | - | - | - | - | |
| Cost of Revenue | 60.85 | 71.71 | 86.17 | 80.28 | 70.17 | 41.29 | |
| Gross Profit | -59.42 | -71.71 | -86.17 | -80.28 | -70.17 | -41.29 | |
| Selling, General & Admin | 143.37 | 116.29 | 54.28 | 30.6 | 26.45 | 16.64 | |
| Operating Expenses | 143.37 | 116.29 | 54.28 | 30.6 | 26.45 | 16.64 | |
| Operating Income | -202.79 | -188 | -140.45 | -110.87 | -96.61 | -57.92 | |
| Interest Expense | -9.31 | -5.79 | - | - | - | - | |
| Interest & Investment Income | 6.59 | 6.44 | 3.9 | 2.23 | 1.09 | 0.9 | |
| Currency Exchange Gain (Loss) | 3.89 | 2.48 | 0.14 | 0.09 | -1.54 | 0.85 | |
| Other Non Operating Income (Expenses) | 2.23 | 3.25 | 8.44 | 15.78 | 15.3 | 9.93 | |
| EBT Excluding Unusual Items | -199.38 | -181.61 | -127.97 | -92.77 | -81.76 | -46.24 | |
| Gain (Loss) on Sale of Investments | 1.83 | 1.56 | 1.33 | -0.14 | -0.58 | - | |
| Pretax Income | -197.55 | -180.05 | -126.64 | -92.91 | -82.34 | -46.24 | |
| Income Tax Expense | 5.55 | 3.39 | - | - | - | - | |
| Net Income | -203.1 | -183.44 | -126.64 | -92.91 | -82.34 | -46.24 | |
| Net Income to Common | -203.1 | -183.44 | -126.64 | -92.91 | -82.34 | -46.24 | |
| Shares Outstanding (Basic) | 51 | 50 | 37 | 28 | 24 | 19 | |
| Shares Outstanding (Diluted) | 51 | 50 | 37 | 28 | 24 | 19 | |
| Shares Change (YoY) | 29.51% | 34.98% | 31.89% | 13.96% | 28.17% | 7.58% | |
| EPS (Basic) | -3.95 | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 | |
| EPS (Diluted) | -3.95 | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 | |
| Free Cash Flow | -167.89 | -153.34 | -89.27 | -76.46 | -79.07 | -30.25 | |
| Free Cash Flow Per Share | -3.26 | -3.09 | -2.43 | -2.74 | -3.23 | -1.58 | |
| Operating Margin | -14220.83% | - | - | - | - | - | |
| Profit Margin | -14242.43% | - | - | - | - | - | |
| Free Cash Flow Margin | -11773.63% | - | - | - | - | - | |
| EBITDA | -201.82 | -187.05 | -139.63 | -110.15 | -96.05 | -57.39 | |
| D&A For EBITDA | 0.97 | 0.94 | 0.82 | 0.72 | 0.56 | 0.54 | |
| EBIT | -202.79 | -188 | -140.45 | -110.87 | -96.61 | -57.92 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.